Cherrill Farnsworth Joins Cianna Medical's Board of Directors


ALISO VIEJO, Calif., Sept. 24, 2015 (GLOBE NEWSWIRE) -- Cianna Medical, Inc., a women's health company dedicated to developing innovative technologies for the treatment of early-stage breast cancer, announced that Cherrill Farnsworth, President and CEO of HealthHelp, has been elected to its Board of Directors.

Ms. Farnsworth founded HealthHelp in 1999, the first company to offer benefits management for radiology and oncology services. HealthHelp has been named to the Inc. 5000 list of fastest-growing private companies nine times since the year 2000. Ms. Farnsworth is an influential national expert on changing health care regulations and regularly advocates radiology management and health care reform before the Centers for Medicare and Medicaid Services as well as other congressional and regulatory bodies.

"Cherrill is a pioneer in the health care industry and we are proud to welcome her to Cianna Medical's Board of Directors," said Jill Anderson, President and Chief Executive Officer of Cianna Medical. "We believe her vision for improving patient outcomes and expertise in specialty benefit management will be extremely valuable as Cianna Medical continues to grow."

Farnsworth is a member of the National Quality Forum and serves on several boards including the American Association of PPOs. She also serves on the faculties of the Radiological Society of North America and American Healthcare Radiology Administrators and on the editorial advisory boards of Imaging Economics and Advanced Imaging. Ms. Farnsworth was named KPMG Peat Marwick High Tech Entrepreneur of the Year and Ernst & Young Entrepreneur of the Year.

About Cianna Medical, Inc.

Cianna Medical develops, manufactures and markets innovative medical technologies that reduce costs, improve quality, and reduce the burden breast cancer treatment places on women and their families. Its SAVI® technologies are FDA-cleared and address unmet needs in the delivery of radiation therapy, tumor localization and surgical guidance.


            

Contact Data